March 22, 2023
Indian Pharma Post
Lupin receives approval from USFDA for Brexpiprazole Tablets
Brexpiprazole Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg, (RLD Rexulti) had estimated annua... See more »
March 21, 2023
Indian Pharma Post
Glenmark receives ANDA approval for Prochlorperazine Maleate Tablets
According to IQVIA sales data for the 12-month period ending January 2023, the Compazine Tablets, 5 m... See more »
March 22, 2023
The Hindu Business Line
Cadila Pharma to expand and upgrade its existing facilities in Gujarat
Cadila commits ₹1,000-cr investment and inks MoU with Gujarat government under Atmanirbhar Gujarat Sc... See more »
March 21, 2023Law 360
Rite Aid Hit With Investor Suit Over DOJ Opioid Action
The U.S. government's claims that Rite Aid Corp. knowingly filled hundreds of thousands of illegal pr... See more »
March 20, 2023Indian Pharma Post
Phase 3 data show Deuruxolitinib significantly improve scalp hair regrowth in Alopecia Areata
The Phase 3 data presented at AAD include a comprehensive review of the THRIVE-AA2 results and furthe... See more »
March 21, 2023Contract Pharma
KBI Biopharma Releases Inaugural FIH Manufacturing Batch at Geneva Facility
Milestone affirms KBI and Selexis SA's Geneva cGMP site is operational and running successfully.... See more »
March 22, 2023Benzinga
Coya Therapeutics Enters First-Of-Its-Kind Partnership With Multi-Billion Dollar Drug Company - Why This Is A Major Moment For Drug Development
Houston-based Coya Therapeutics (NASDAQ: COYA) has entered into a partnership with Dr. Reddy's Labora... See more »
March 20, 2023The Hindu Business Line
Glenmark gets USFDA nod to market generic medication
Used to treat schizophrenia and controlling nausea, the Glenmark's prochlorperazine maleate tablets a... See more »
March 22, 2023AsiaNet Pakistan
EQUITY ALERT: ROSEN, A LEADING LAW FIRM, Encourages Rite Aid Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm - RAD
NEW YORK, March 21, 2023 (GLOBE NEWSWIRE) - WHY: Rosen Law Firm, a global investor rights law firm, a... See more »
March 22, 2023
Indian Pharma Post
Lupin receives approval from USFDA for Brexpiprazole Tablets
Brexpiprazole Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg, (RLD Rexulti) had estimated annua... See more »
March 21, 2023
Indian Pharma Post
Glenmark receives ANDA approval for Prochlorperazine Maleate Tablets
According to IQVIA sales data for the 12-month period ending January 2023, the Compazine Tablets, 5 m... See more »
March 22, 2023
The Hindu Business Line
Cadila Pharma to expand and upgrade its existing facilities in Gujarat
Cadila commits ₹1,000-cr investment and inks MoU with Gujarat government under Atmanirbhar Gujarat Sc... See more »
March 21, 2023Law 360
Rite Aid Hit With Investor Suit Over DOJ Opioid Action
The U.S. government's claims that Rite Aid Corp. knowingly filled hundreds of thousands of illegal pr... See more »
March 20, 2023Indian Pharma Post
Phase 3 data show Deuruxolitinib significantly improve scalp hair regrowth in Alopecia Areata
The Phase 3 data presented at AAD include a comprehensive review of the THRIVE-AA2 results and furthe... See more »
March 21, 2023Contract Pharma
KBI Biopharma Releases Inaugural FIH Manufacturing Batch at Geneva Facility
Milestone affirms KBI and Selexis SA's Geneva cGMP site is operational and running successfully.... See more »
March 22, 2023Benzinga
Coya Therapeutics Enters First-Of-Its-Kind Partnership With Multi-Billion Dollar Drug Company - Why This Is A Major Moment For Drug Development
Houston-based Coya Therapeutics (NASDAQ: COYA) has entered into a partnership with Dr. Reddy's Labora... See more »
March 20, 2023The Hindu Business Line
Glenmark gets USFDA nod to market generic medication
Used to treat schizophrenia and controlling nausea, the Glenmark's prochlorperazine maleate tablets a... See more »
March 22, 2023AsiaNet Pakistan
EQUITY ALERT: ROSEN, A LEADING LAW FIRM, Encourages Rite Aid Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm - RAD
NEW YORK, March 21, 2023 (GLOBE NEWSWIRE) - WHY: Rosen Law Firm, a global investor rights law firm, a... See more »
Dr.Reddy's is an India-based multinational pharmaceutical company that manufactures and markets medicines, active pharmaceutical ingredients and intermediates.
Read more